{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:02:19Z","timestamp":1783422139863,"version":"3.54.6"},"reference-count":16,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,1,29]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p>We present a case of 50-year-old man with history of ulcerative right axillary mass for 6 months. Axillary lymphadenopathy and organomegaly were absent. Microscopic examination showed sheets of pleomorphic cells which were mitotically active. Distinctive myxoid change was seen throughout the tumor. These cells were strongly positive for CD30 and vimentin but were negative for CD3, CD5, CD20, CD15, anaplastic lymphoma kinase protein (ALK), CD56, cytokeratin, melan A, desmin, myogenin, CD68, S100, epithelial membrane antigen and CD34. The final diagnosis of primary cutaneous ALK-negative T-cell anaplastic large cell lymphoma (PCALCL), myxoid variant was made. Work-up revealed no systemic involvement. The patient received eight cycles of cyclophosphamide, doxorubicin, vincristine, prednisone and etoposide chemotherapy with complete resolution of disease. This case report highlights that a high index of suspicion is necessary in patients of PCALCL due to varied clinical presentation, and to discuss in brief the histopathologic and immunophenotypic features of this entity along with its differential diagnosis.<\/jats:p>","DOI":"10.1136\/bcr-2020-239350","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T10:05:48Z","timestamp":1612692348000},"page":"e239350","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["ALK-negative primary cutaneous T-cell anaplastic large cell lymphoma, myxoid variant; masquerading as sarcoma: unveiling the diagnostic dilemma"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-1575","authenticated-orcid":false,"given":"Medha","family":"Misra","sequence":"first","affiliation":[{"name":"Department of Pathology, King George's Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivanjali","family":"Raghuvanshi","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George's Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu Mati","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Pathology, King George's Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra Prasad","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, King George's Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2025082700361264000_14.2.e239350.1","first-page":"439","article-title":"Who classification of tumours of haematopoietic and lymphoid tissues","volume":"22008","author":"Swerdlow","year":"2008","journal-title":"WHO classification of tumours"},{"key":"2025082700361264000_14.2.e239350.2","first-page":"3653","article-title":"Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch cutaneous lymphoma group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"2025082700361264000_14.2.e239350.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70491-3"},{"key":"2025082700361264000_14.2.e239350.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134270"},{"key":"2025082700361264000_14.2.e239350.5","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.6.445"},{"key":"2025082700361264000_14.2.e239350.6","first-page":"2697","article-title":"ALK+ lymphoma: clinico-pathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"key":"2025082700361264000_14.2.e239350.7","first-page":"3591","article-title":"CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology","volume":"92","author":"Brugi\u00e8res","year":"1998","journal-title":"Blood"},{"key":"2025082700361264000_14.2.e239350.8","first-page":"3681","article-title":"Cd30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"2025082700361264000_14.2.e239350.9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00000478-199010000-00013","article-title":"Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma","volume":"14","author":"Chan","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"2025082700361264000_14.2.e239350.10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00125480-199809000-00002","article-title":"Anaplastic large cell lymphoma: redefining its morphologic spectrum and importance of recognition of the ALK-positive subset","volume":"5","author":"Chan","year":"1998","journal-title":"Adv Anat Pathol"},{"key":"2025082700361264000_14.2.e239350.11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1600-0560.2012.01911.x","article-title":"Myxoid variant of anaplastic large cell lymphoma involving the skin: a case report","volume":"39","author":"Gable","year":"2012","journal-title":"J Cutan Pathol"},{"key":"2025082700361264000_14.2.e239350.12","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.323"},{"key":"2025082700361264000_14.2.e239350.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"2025082700361264000_14.2.e239350.14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00000372-200010000-00007","article-title":"Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype bearing the t(2;5)(p23;q35) translocation and presenting in a child","volume":"22","author":"Gould","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"2025082700361264000_14.2.e239350.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.028"},{"key":"2025082700361264000_14.2.e239350.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)02484-8"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-239350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:36:25Z","timestamp":1756280185000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-239350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,5]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/bcr-2020-239350"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-239350","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}